Common reasons for the efficacy of Leborexan (Daveco) to fail and methods to improve its efficacy
Lemborexant is an oral dual antagonist that helps improve difficulty falling asleep and maintain sleep mainly by inhibiting the activity of melanin receptors (orexin receptor) in the brain. It has shown good efficacy in the treatment of insomnia, but its efficacy may still be weakened or ineffective during clinical use. The failure of efficacy is usually related to a variety of factors, including the patient's own physiological state, comorbid diseases, lifestyle habits, and medication compliance.
A common cause is the development of drug tolerance in patients. Long-term continuous use of leborexan may cause the body's sensitivity to the drug to decrease, thereby reducing its sleep-improving effect. In addition, patients with comorbid anxiety, depression or other sleep disorders may also experience medication that is not as effective as expected due to multiple factors. In these cases, relying solely on medications may not completely resolve the sleep problem.
Methods to improve drug efficacy include optimizing medication taking times and improving lifestyle. Leborexan should be taken 30 minutes before going to bed, and ensure that the patient has more than 7 hours of continuous sleep to achieve the best effect. At the same time, maintaining a regular sleep schedule and avoiding drinking caffeinated drinks or using electronic devices before going to bed can enhance the effect of the medicine. For patients who develop tolerance or weakened drug efficacy, doctors may adjust the dose or use the drug intermittently after evaluation to delay the emergence of drug resistance.
In addition, combining non-pharmacological intervention is also an important measure to improve the efficacy. Cognitive behavioral therapy, relaxation training, sleep environment optimization and other methods can be used in conjunction with Lebrasin to improve the speed of falling asleep and the quality of sleep. Regular follow-up and sleep assessment help doctors adjust treatment plans according to the patient's actual condition, thereby maximizing the clinical benefit of the drug while reducing the risk of side effects and drug dependence.
Reference link:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)